- €6.03bn
- €11.28bn
- €14.76bn
- 30
- 85
- 68
- 67
2019 December 31st | R2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Other Revenue | |||||
Total Revenue | 7,324 | 6,848 | 11,549 | 23,156 | 14,758 |
Cost of Revenue | |||||
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 6,629 | 6,294 | 10,889 | 22,317 | 13,740 |
Operating Profit | 695 | 554 | 660 | 839 | 1,018 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 581 | 473 | 590 | 751 | 879 |
Provision for Income Taxes | |||||
Net Income After Taxes | 392 | 374 | 554 | 407 | 680 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 389 | 364 | 504 | 401 | 659 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 389 | 364 | 504 | 401 | 659 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.125 | 0.12 | 0.169 | 0.088 | 0.21 |
Dividends per Share |